These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15848294)

  • 1. Optimization of empirical antibiotic selection for suspected Gram-negative bacteraemia in the emergency department.
    Benenson S; Yinnon AM; Schlesinger Y; Rudensky B; Raveh D
    Int J Antimicrob Agents; 2005 May; 25(5):398-403. PubMed ID: 15848294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
    J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-factors for gastrointestinal colonisation with resistant Enterobacteriaceae among hospitalised patients: a prospective study.
    Lepelletier D; Caroff N; Riochet D; Bizouarn P; Bourdeau A; Le Gallou F; Espaze E; Reynaud A; Richet H
    Clin Microbiol Infect; 2006 Oct; 12(10):974-9. PubMed ID: 16961633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired bacteraemia and antibiotic resistance. Trends during a 17-year period in a Danish county.
    Pedersen G; Schønheyder HC; Kristensen B; Sørensen HT
    Dan Med Bull; 2000 Sep; 47(4):296-300. PubMed ID: 11064832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
    Huang SS; Lee MH; Leu HS
    J Microbiol Immunol Infect; 2006 Dec; 39(6):496-502. PubMed ID: 17164953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
    Fortún J; Grill F; Martín-Dávila P; Blázquez J; Tato M; Sánchez-Corral J; García-San Miguel L; Moreno S
    J Antimicrob Chemother; 2006 Oct; 58(4):816-21. PubMed ID: 16899468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam.
    Jones SL; Nguyen VK; Nguyen TM; Athan E
    Trop Med Int Health; 2006 Nov; 11(11):1725-30. PubMed ID: 17054753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive model of antimicrobial-resistant gram-negative bacteremia at the ED.
    Chiang WC; Chen SY; Chien KL; Wu GH; Yen AM; Su CP; Lee CC; Chen YC; Chang SC; Chen SC; Chen WJ; Chen TH
    Am J Emerg Med; 2007 Jul; 25(6):597-607. PubMed ID: 17606081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
    Jónsdóttir K; Kristinsson KG
    Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjustment of antibiotic treatment according to the results of blood cultures leads to decreased antibiotic use and costs.
    Berild D; Mohseni A; Diep LM; Jensenius M; Ringertz SH
    J Antimicrob Chemother; 2006 Feb; 57(2):326-30. PubMed ID: 16387751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.
    Livermore DM; James D; Reacher M; Graham C; Nichols T; Stephens P; Johnson AP; George RC
    Emerg Infect Dis; 2002 May; 8(5):473-8. PubMed ID: 11996681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region.
    Laupland KB; Parkins MD; Ross T; Pitout JD
    Clin Microbiol Infect; 2007 Jul; 13(7):683-8. PubMed ID: 17403132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda.
    Bachou H; Tylleskär T; Kaddu-Mulindwa DH; Tumwine JK
    BMC Infect Dis; 2006 Nov; 6():160. PubMed ID: 17090299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunovic-Kamberovic S
    J Antimicrob Chemother; 2006 Aug; 58(2):344-8. PubMed ID: 16775214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and causative organisms in microbial keratitis.
    Green M; Apel A; Stapleton F
    Cornea; 2008 Jan; 27(1):22-7. PubMed ID: 18245962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
    Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
    Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.